flag flag  

Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease : attrition rate and evolution of disease activity.

Description : This study is based on the results from a Belgian expanded access program in which patients with active refractory and erosive rheumatoid arthritis (RA) were treated with intravenous infusions of infliximab in combination with methotrexate. The objectives of this study were to evaluate the continuat...
Language(s) : English
Subject(s) : Antibodies, Monoclonal - administration & dosage, adverse effects, therapeutic use , Antirheumatic Agents - administration & dosage, adverse effects, therapeutic use , Infusions, Intravenous , Kaplan-Meier Estimate , Longitudinal Studies , Male , Methotrexate - therapeutic use , Middle Aged , Severity of Illness Index , Treatment Outcome , Arthritis, Rheumatoid - drug therapy , Belgium , Disease Progression , Drug Therapy, Combination , Female , Follow-Up Studies , Health Surveys , Humans
Publisher(s) : BioMed Central Ltd.
Contributor(s) : UCL - (SLuc) Service de rhumatologie , UCL - SSS/IREC/RUMA - Pôle de Pathologies rhumatismales
Source(s) : Arthritis Research & Therapy, Vol. 12, no. 3, p. R77 (2010)
Publication Date(s) : 2010-01-01